Not recommended for diagnosing congenital infections in newborns; tests should be selected individually to target the most likely infectious agents. May be used in pregnant women to assess past exposure or immunization to Toxoplasma, Rubella, CMV, and HSV.
Semi-Quantitative Chemiluminescent Immunoassay
Within 24 hours
New York DOH Approval Status
Serum Separator Tube (SST).
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 1 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Mark specimens plainly as "acute" or "convalescent."
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|0050165||Cytomegalovirus Antibody, IgG||
|0050293||Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG||
|0050771||Rubella Antibody, IgG||
|0050770||Toxoplasma gondii Antibody, IgG||Effective March 3, 2014
Refer to report.
This test should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
86644; 86694; 86762; 86777
|Component Test Code*||Component Chart Name||LOINC|
|0050165||CMV Antibody IgG||5124-3|
|0050286||HSV Type 1/2 Combined Ab, IgG||27948-9|
|0050770||Toxoplasma gondii Ab, IgG||8039-0|
|0050771||Rubella Antibody IgG||8014-3|
- CMV Antibody IgG, HSV Type 1/2 Combined Ab, IgG
- Rubella Antibody IgG
- Torch panel
- Toxoplasma gondii Ab, IgG